Page last updated: 2024-10-25

clenbuterol and Ventricular Dysfunction, Left

clenbuterol has been researched along with Ventricular Dysfunction, Left in 2 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birks, EJ1
George, RS1
Hedger, M1
Bahrami, T1
Wilton, P1
Bowles, CT1
Webb, C1
Bougard, R1
Amrani, M1
Yacoub, MH1
Dreyfus, G1
Khaghani, A1
George, I1
Xydas, S1
Mancini, DM1
Lamanca, J1
DiTullio, M1
Marboe, CC1
Shane, E1
Schulman, AR1
Colley, PM1
Petrilli, CM1
Naka, Y1
Oz, MC1
Maybaum, S1

Trials

1 trial available for clenbuterol and Ventricular Dysfunction, Left

ArticleYear
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:9

    Topics: Adrenergic beta-Agonists; Body Composition; Cardiac Output, Low; Clenbuterol; Dose-Response Relation

2006

Other Studies

1 other study available for clenbuterol and Ventricular Dysfunction, Left

ArticleYear
Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
    Circulation, 2011, Feb-01, Volume: 123, Issue:4

    Topics: Adult; Cardiomyopathy, Dilated; Cardiovascular Agents; Clenbuterol; Female; Heart Failure; Heart-Ass

2011